Samsara BioCapital’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,803
| Closed | -$176K | – | 36 |
|
|
2025
Q1 | $176K | Sell |
27,803
-11,511
| -29% | -$72.7K | 0.03% | 33 |
|
|
2024
Q4 | $406K | Sell |
39,314
-16,291
| -29% | -$168K | 0.06% | 38 |
|
|
2024
Q3 | $715K | Hold |
55,605
| – | – | 0.14% | 35 |
|
|
2024
Q2 | $769K | Hold |
55,605
| – | – | 0.16% | 33 |
|
|
2024
Q1 | $17.3M | Hold |
55,605
| – | – | 2.68% | 8 |
|
|
2023
Q4 | $14.6M | Hold |
55,605
| – | – | 2.27% | 11 |
|
|
2023
Q3 | $10.9M | Hold |
55,605
| – | – | 3.33% | 8 |
|
|
2023
Q2 | $11.4M | Buy |
55,605
+20,060
| +56% | +$4.12M | 2.01% | 10 |
|
|
2023
Q1 | $3.57M | Hold |
35,545
| – | – | 0.74% | 25 |
|
|
2022
Q4 | $5.58M | Hold |
35,545
| – | – | 1.2% | 18 |
|
|
2022
Q3 | $8.9M | Hold |
35,545
| – | – | 2.08% | 13 |
|
|
2022
Q2 | $10M | Buy |
+35,545
| New | +$10M | 2.68% | 7 |
|